ZP3 Expression in Pancreatic Adenocarcinoma: Its Implications for the Prognosis and Therapy
ZP3 has the potential to serve as a prognostic biomarker and therapeutic target for patients with PAAD.
Authors
- Guizhen Lyu (ORCID: https://orcid.org/0000-0002-9284-7318)
- Dongbing Li (ORCID: https://orcid.org/0000-0002-5227-9643)
Institutions
- Beijing Zhongke Science and Technology (China) (CN)
Publication Details
- Journal
- Protein and Peptide Letters
- Published
- 2025-01-10
- DOI
- https://doi.org/10.2174/0109298665350171241204153202
- Citations
- 6
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 6.27